Some movement in the U.S. toward consideration of better trial design and analysis is has been afoot, but not a mechanism for offering independent analysis for inclusion in published reports.
The problem actually is not going to be verification in the sense that this international consultation and analysismechanism will actually tell us a lot of what we need to know.